Effect of catgut implantation at acupoint on gonadal hormone and beta-endorphin in patients of climacteric syndrome.
- Author:
Yue-mei LI
1
;
Li-xing ZHUANG
;
Dong-shu ZHANG
;
Yi-feng LUO
Author Information
- Publication Type:Journal Article
- MeSH: Acupuncture Points; Acupuncture Therapy; Adult; Catgut; Female; Gonadal Hormones; metabolism; Humans; Middle Aged; Premenopause; metabolism; Prostheses and Implants; beta-Endorphin; metabolism
- From: Chinese Acupuncture & Moxibustion 2009;29(11):865-867
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo explore the clinical therapeutic effect of catgut implantation at acupoint on climacteric syndrome (CS) and its mechanism.
METHODSSixty cases were randomly divided into a catgut implantation group and a western medicine group, 30 cases in each group. The catgut implantation group was treated by catgut implantation at Shenshu (BL 23), Zigong (EX-CA 1), Sanyinjiao (SP 6). The western medicine group was treated by oral administration of Diethylstilbestrol tablet. Their therapeutic effects and changes of content of follicle-stimulating hormone (FSH), luteotrophic hormone (LH), estradiol (E2) and beta-endorphin (beta-EP) in serum were observed.
RESULTSThe total effective rate was 93.3% in the catgut implantation group and 70.0% in the western medicine group with a significant difference between the two groups (P < 0.05). After treatment, the beta-EP concentration in the catgutation implant group was significantly increased (P < 0.05), the FSH concentration was significantly reduced and E2 concentration was significantly increased as compared with those in the western medicine group (P < 0.05, P < 0.01).
CONCLUSIONCatgut implantation at acupoint has an obvious therapeutic effects on CS. It can significantly improve the ovaries function and has a favorable regulative action on the endogenous opioid peptides.
